Post-Traumatic Stress Disorder

Autorzy:

Wydawca: OUP USA

ISBN: 9780190259440

This item is printed to order. Items which are printed to order are normally despatched and charged within 4-6 weeks.

1 111,50 zł

1 000,35 zł Zniżka 111,15 zł Brutto

Najniższa cena w okresie 30 dni przed promocją: 1 000,35 zł

Ilość

Od 4 do 6 tygodni

Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

This volume brings together the leaders in the field of PTSD research to present an up-to-date summary and understanding of this complex disorder. All of our current knowledge and controversies concerning the diagnosis, epidemiology, course, pathophysiology and treatment are described in detail. The evidence for efficacy for each of the different forms of psychotherapy and pharmacotherapy is reviewed. Particular attention is paid to at-risk groups, including minorities, and coverageof PTSD throughout the world is reviewed as well. The authors present state-of-the-art findings in genetics, epigenetics, neurotransmitter function and brain imaging to provide the most current and comprehensive review of this burgeoning field.

Szczegóły produktu

Wydawca OUP USA

Indeks 88228

EAN13 9780190259440

ISBN 9780190259440

Opis

Rok wydania: 2018
Numer wydania: 1
Oprawa: twarda
Liczba stron: 840
Wymiary (mm): 216 x 279
Waga (g): 2064

Section I:: History and Nosology of PTSD; 1. Conceptual History of PTSD; Arieh Y. Shalev and Charles R. Marmar; 2. DSM-5 Diagnostic Criteria for PTSD; Frank Weathers; 3. Measures of PTSD Symptom Severity; Kelly S. Parker-Builbert, Samantha S. Moshier, Brian P. Marx, and Terrence M. Keane; 4. PTSD and Traumatic Brain Injury; Richard Bryant; 5. PTSD and Medical Illness; Peter Roy-Byrne and Murray B. Stein; 6. PTSD and Neurodegenerative Disorders; David Lowenstein; Section II:: Epidemiology of PTSD; 7. Trauma and PTSD in the United States; Ronald Kessler; 8. Trauma and PTS in Europe; Sebastian Trautmann and Hans-Ulrich Wittchen; 9. PTSD in Low- and Middle-Income Countries; Soraya Seedat and Sharain Suliman; 10. PTSD and War; Gary H. Wynn, David M. Benedek, Joshua C. Morganstein, and Robert J. Ursano; 11. PTSD Associated With Disaster; Carol North; 12. PTSD in Children; Zelde Espinel and Jon Shaw; 13. PTSD and Women; Sara Kornfield and C. Neil Epperson; 14. PTSD in LGBT Populations; Andrew Wawrzyniak; Section III:: Pathophysiology in PTSD; 15. Executive Function in PTSD; Jennifer Newman and Charles Marmar; 16. PTSD and Cognition; Phillip D. Harvey and Felicia Gould; 17. Epigenetics and PTSD; Michael Meaney and Rachel Yehuda; 18. Structural and Functional Brain Imaging; Aaron Heller; 19. Neurobiological Pathways Involved In Fear, Stress, and PTSD; Christine Heim, KatharinaSchultebraucks, Charles R. Marmar, and Charles B. Nemeroff; 20. Neuroendocrinology; Rachel Yehuda; 21. Psychoneuroimmunology of PTSD; Carmine Pariente and Becky Bind; 22. The Psychophysiology of PTSD; Suzanne L. Pineles and Scott Orr; 23. Sleep and PTSD; Tom Mellman; 24. Animal Models for PTSD; Elizabeth Perkins, Shaun Brothers, and Charles Nemeroff; Section IV:: Risk Factors; 25. Child Abuse and Neglect as Risk Factors for PTSD; Nils C. Westfall and Charles B. Nemeroff; 26. Genetic Approaches to PTSD; Guia Guffanti, Milissa L. Kaufman, Lauren A. M. Lebois, and Kerry J. Ressler; 27. Multigenerational Legacies of Trauma; Yael Danieli and Brian Engdahl; 28. PTSD and Co-Occurring Substance Use Disorders; Amanda K. Gilmore, Kaitlin E. Bountress, Emma L. Barrett, Sudie E. Back, and Kathleen T. Brady; 29. Ethnicity; Nnamdi Pole; Section V:: Treatment; 30. Prolonged Exposure Therapy for PTSD; Lily A. Brown, David Yusko, Hallie Tannahill, and Edna B. Foa; 31. Psychotherapy:: Cognitive Processing Therapy; Patty Resick and Candice Monson; 32. Psychotherapy:: Psychodynamic; Glen O. Gabbard; 33. Group Therapy; Denise Sloan; 34. Antidepressants; Nastassja Koen, T. Amos, J. Ipser, and Dan J. Stein; 35. Pharmacologic Treatment of Nightmares, Sleep Disturbance, and Daytime Hyperarousal in PTSD; Rebecca C. Hendrickson and Murray Raskind; 36. Antipsychotics; Henry A. Nasrallah; 37. Prevention of PTSD; Arieh Y. Shalev, Anna C. Barbano, Wei Qi and Charles R. Marmar; 38. The Role of Gluccocorticoids in the (Mal)adaptive Response to Traumatic Experience; Hagit Cohen and Joseph Zohar; 39. Neuromodulation Methods in PTSD; Doron Todder, Keren Avirame, and Hagit Cohen; 40. Investigational Agents; John Krystal and Benjamin Kelmendi; 41. Complementary and Alternative Medicine; Emmeline Edwards;